Literature DB >> 2533473

In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.

H Talbot1, B Romanowski.   

Abstract

In vitro lomefloxacin was highly active against 208 penicillin-susceptible and -resistant isolates of Neisseria gonorrhoeae. However, its MIC and MBC against 10 isolates of Chlamydia trachomatis were 2 and greater than 4 micrograms/ml, respectively.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2533473      PMCID： PMC172820          DOI： 10.1128/AAC.33.12.2049

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation.

Authors:  C K Lee; W R Bowie; E R Alexander
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  In vitro drug susceptibility of Chlamydia sp. strain TWAR.

Authors:  C C Kuo; J T Grayston
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

3.  In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis.

Authors:  W R Bowie
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

4.  Clinical use of the quinolones.

Authors:  H C Neu
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

5.  In-vitro and in-vivo activity of parenterally administered beta-lactam antibiotics against Chlamydia trachomatis.

Authors:  D H Martin; J G Pastorek; S Faro
Journal:  Sex Transm Dis       Date:  1986 Apr-Jun       Impact factor: 2.830

6.  In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis.

Authors:  M R Hammerschlag; A Gleyzer
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

7.  In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.

Authors:  J Segreti; H A Kessler; K S Kapell; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

8.  Ultrastructural analysis of the effects of penicillin and chlortetracycline on the development of a genital tract Chlamydia.

Authors:  M J Kramer; F B Gordon
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

9.  Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.

Authors:  W R Bowie; C K Lee; E R Alexander
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

10.  Cultivation of Chlamydia trachomatis in cycloheximide-treated mccoy cells.

Authors:  K T Ripa; P A Mårdh
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948
View more
  4 in total

1.  In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis.

Authors:  Shuxian Shang; Longqing Xia; Mingying Zhong; Jinping Zhang; Jianbin Zhao; Xiangdong Gong; David Mabey; Qianqiu Wang
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 2.  Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A N Wadworth; K L Goa
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

3.  In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay.

Authors:  H Torres; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

4.  Homoplastic single nucleotide polymorphisms contributed to phenotypic diversity in Mycobacterium tuberculosis.

Authors:  Pornpen Tantivitayakul; Wuthiwat Ruangchai; Tada Juthayothin; Nat Smittipat; Areeya Disratthakit; Surakameth Mahasirimongkol; Wasna Viratyosin; Katsushi Tokunaga; Prasit Palittapongarnpim
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.